These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34929300)

  • 1. Mitochondrial dysfunction and mitochondrial therapies in heart failure.
    Wu C; Zhang Z; Zhang W; Liu X
    Pharmacol Res; 2022 Jan; 175():106038. PubMed ID: 34929300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
    Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
    Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the mitochondria-inflammation axis: Insights and therapeutic strategies for heart failure.
    Zuo B; Fan X; Xu D; Zhao L; Zhang B; Li X
    Int Immunopharmacol; 2024 Sep; 139():112697. PubMed ID: 39024750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.
    Akhmedov AT; Rybin V; Marín-García J
    Heart Fail Rev; 2015 Mar; 20(2):227-49. PubMed ID: 25192828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial centrality in heart failure.
    Marín-García J; Goldenthal MJ
    Heart Fail Rev; 2008 Jun; 13(2):137-50. PubMed ID: 18185992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria as Therapeutic Targets in Heart Failure.
    Schwemmlein J; Maack C; Bertero E
    Curr Heart Fail Rep; 2022 Apr; 19(2):27-37. PubMed ID: 35147851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.
    Brown DA; Perry JB; Allen ME; Sabbah HN; Stauffer BL; Shaikh SR; Cleland JG; Colucci WS; Butler J; Voors AA; Anker SD; Pitt B; Pieske B; Filippatos G; Greene SJ; Gheorghiade M
    Nat Rev Cardiol; 2017 Apr; 14(4):238-250. PubMed ID: 28004807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure.
    Sheeran FL; Pepe S
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E449-60. PubMed ID: 27406740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects of impaired mitochondrial function in heart failure.
    Rosca MG; Hoppel CL
    J Bioenerg Biomembr; 2009 Apr; 41(2):107-12. PubMed ID: 19347572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dynamics and cell death in heart failure.
    Marín-García J; Akhmedov AT
    Heart Fail Rev; 2016 Mar; 21(2):123-36. PubMed ID: 26872674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.
    Dietl A; Maack C
    Curr Heart Fail Rep; 2017 Aug; 14(4):338-349. PubMed ID: 28656516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial-nuclear cross-talk in the aging and failing heart.
    Marín-García J; Pi Y; Goldenthal MJ
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):477-91. PubMed ID: 17119872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting mitochondrial dysfunction in the treatment of heart failure.
    Sabbah HN
    Expert Rev Cardiovasc Ther; 2016 Dec; 14(12):1305-1313. PubMed ID: 27758146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Ca
    Cortassa S; Juhaszova M; Aon MA; Zorov DB; Sollott SJ
    J Mol Cell Cardiol; 2021 Feb; 151():113-125. PubMed ID: 33301801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and heart failure.
    Tsutsui H; Kinugawa S; Matsushima S
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2181-90. PubMed ID: 21949114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy deficiency in the failing heart: linking increased reactive oxygen species and disruption of oxidative phosphorylation rate.
    Sheeran FL; Pepe S
    Biochim Biophys Acta; 2006; 1757(5-6):543-52. PubMed ID: 16631107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart.
    Lemieux H; Semsroth S; Antretter H; Höfer D; Gnaiger E
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1729-38. PubMed ID: 21871578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial calcium overload is a key determinant in heart failure.
    Santulli G; Xie W; Reiken SR; Marks AR
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11389-94. PubMed ID: 26217001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal tolerance and thermal sensitivity of heart mitochondria: Mitochondrial integrity and ROS production.
    Christen F; Desrosiers V; Dupont-Cyr BA; Vandenberg GW; Le François NR; Tardif JC; Dufresne F; Lamarre SG; Blier PU
    Free Radic Biol Med; 2018 Feb; 116():11-18. PubMed ID: 29294390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.